News + Filings Charts Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Shin Nippon Biomedical Laboratories, Ltd. (2395)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Shin Nippon Biomedical Laboratories, Ltd. (10% Owner) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.|
Txns:
| Bought 22,053,581 shares
@ $0.91, valued at
$20.1M
Bought 8,423,732 shares
@ $0.91, valued at
$7.7M
|
|
| 06/08/2023 |
SC 13D/A
| Shin Nippon Biomedical Laboratories, Ltd. reports a 100% stake in SATSUMA PHARMACEUTICALS, INC. |
| 06/08/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 05/26/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 05/05/2023 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 04/17/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/17/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/12/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/31/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 02/20/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/26/2018 |
SC 13D/A
| Shin Nippon Biomedical Laboratories, Ltd. reports a 21.1% stake in WAVE Life Sciences Ltd. |
| 09/29/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/26/2016 |
SC 13D/A
| Shin Nippon Biomedical Laboratories, Ltd. reports a 21.5% stake in WAVE Life Sciences Ltd. |
|
|